Healthcare · Pharmaceuticals & Biotechnology
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #None of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 27 Apr 2026 | SUSHMA SHEKHAR | Bulk | Buy | 15,000 | 20.3100 | BSE |
| 27 Apr 2026 | DINESH DALICHAND VORA HUF | Bulk | Sell | 18,000 | 20.3100 | BSE |
| 9 Apr 2026 | SUMITA SINGH KADIAN | Bulk | Sell | 24,000 | 19.3500 | BSE |
| 9 Apr 2026 | MONIKA MALIK | Bulk | Sell | 24,000 | 19.3500 | BSE |
| 9 Apr 2026 | PUSHPA DEVI | Bulk | Sell | 24,000 | 19.3500 | BSE |
| 9 Apr 2026 | EMRALD COMMERCIAL LIMITED | Bulk | Sell | 36,000 | 19.3500 | BSE |
| 9 Apr 2026 | VENKATESHWARA INDUSTRIAL PROMOTION CO LIMITED | Bulk | Sell | 66,000 | 19.3500 | BSE |
| 9 Apr 2026 | SUSHMA SHEKHAR | Bulk | Buy | 174,000 | 19.3500 | BSE |
| 24 Mar 2026 | VISHAL MAHESH WAGHELA | Bulk | Buy | 33,000 | 13.4000 | BSE |
| 24 Mar 2026 | ALTIZEN VENTURES LLP | Bulk | Sell | 33,000 | 13.4000 | BSE |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| — | NAME_CHANGE | Name changed from Fabino Life Sciences Limited to FABINO ENTERPRISES LIMITED |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 1 Oct 2026 | AGM/EGM | Fabino Enterprises Ltd - 543444 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| 29 Sep 2026 | AGM/EGM | Fabino Enterprises Ltd - 543444 - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| 29 Sep 2026 | Others | Fabino Enterprises Ltd - 543444 - Board Meeting Outcome for Meeting Of Board Of Director Held On September 29, 2026. |
| 29 Sep 2026 | Company Update | Fabino Enterprises Ltd - 543444 - Announcement under Regulation 30 (LODR)-Change in Management |
| 25 Sep 2026 | Insider Trading / SAST | Fabino Enterprises Ltd - 543444 - Closure of Trading Window |
| 4 Sep 2026 | AGM/EGM | Fabino Enterprises Ltd - 543444 - Notice Of 15Th Annual General Meeting To Be Held On Tuesday, September 29, 2026 |
| 4 Sep 2026 | Company Update | Fabino Enterprises Ltd - 543444 - Announcement under Regulation 30 (LODR)-Change in Management |
| 4 Sep 2026 | Corp. Action | Fabino Enterprises Ltd - 543444 - Intimation Of Book Closure For 15Th Annual General Meeting |
| 4 Sep 2026 | Others | Fabino Enterprises Ltd - 543444 - Reg. 34 (1) Annual Report. |
| 4 Sep 2026 | Others | Fabino Enterprises Ltd - 543444 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, September 04, 2026. |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
